These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7795274)

  • 1. Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo.
    Naylor MA; Adams GE; Haigh A; Cole S; Jenner T; Robertson N; Siemann D; Stephens MA; Stratford IJ
    Anticancer Drugs; 1995 Apr; 6(2):259-69. PubMed ID: 7795274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay.
    Langmuir VK; Laderoute KR; Mendonca HL; Sutherland RM; Hei TK; Liu SX; Hall EJ; Naylor MA; Adams GE
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):79-84. PubMed ID: 12118568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic potential of bifunctional bioreductive drugs.
    Hei TK; Liu SX; Hall EJ
    Br J Cancer Suppl; 1996 Jul; 27():S57-60. PubMed ID: 8763847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
    Lee HH; Wilson WR; Denny WA
    Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233.
    Zeman EM; Hirst VK; Lemmon MJ; Brown JM
    Radiother Oncol; 1988 Jul; 12(3):209-18. PubMed ID: 3175048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
    Naylor MA; Stephens MA; Nolan J; Sutton B; Tocher JH; Fielden EM; Adams GE; Stratford IJ
    Anticancer Drug Des; 1993 Dec; 8(6):439-61. PubMed ID: 8286012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
    Zeman EM; Brown JM; Lemmon MJ; Hirst VK; Lee WW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1239-42. PubMed ID: 3744945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):537-42. PubMed ID: 7880736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductase.
    Barham HM; Stratford IJ
    Biochem Pharmacol; 1996 Mar; 51(6):829-37. PubMed ID: 8602879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW; Hay MP; Denny WA; Wilson WR
    Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
    Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
    J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity.
    Naylor MA; Sutton BM; Nolan J; O'Neill P; Fielden EM; Adams GE; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):333-7. PubMed ID: 8195029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxicity of pyrazine-2-diazohydroxide: specificity for hypoxic cells and effects of microsomal coincubation.
    Brodfüehrer JI; Moore DJ; Melder DC; Wilke TJ; Powis G
    Invest New Drugs; 1988 Apr; 6(1):3-9. PubMed ID: 3410664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
    Olive PL
    Acta Oncol; 1995; 34(3):301-5. PubMed ID: 7779413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of bioreductive drug toxicity in murine tumours by inhibition of the activity of nitric oxide synthase.
    Butler SA; Wood PJ; Cole S; Williams C; Adams GE; Stratford IJ
    Br J Cancer; 1997; 76(4):438-44. PubMed ID: 9275019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies with bifunctional bioreductive drugs. II. Cytotoxicity assayed with A-549 lung carcinoma cells of human origin.
    Roizin-Towle L; Pirro JP; Hall EJ
    Radiat Res; 1990 Oct; 124(1 Suppl):S50-5. PubMed ID: 2236511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel N-oxides as bioreductive drugs.
    Naylor MA
    Oncol Res; 1994; 6(10-11):483-91. PubMed ID: 7620216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.